Antiphospholipid antibodies in young women with and without oral contraceptive use

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 1, 2003, Pages 57-60

  Vad, Szilvia ^a   Lakos, Gabriella ^b   Kiss, Emese ^b   Sipka, Sàndor ^b   Csorba, Roland ^a   Poka, Robert ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Antiphospholipid antibodies; Oral contraceptive use

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CYPROTERONE; DESOGESTREL; GESTAGEN; GESTODENE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION DISORDERS; CONTRACEPTIVES, ORAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN ISOTYPES; ODDS RATIO; PROSPECTIVE STUDIES;

EID: 12244254457     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200301000-00010     Document Type: Article

References (15)

1. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353:1348-1353.
2. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ . Anticardiolipin antibodies and the risk for ischaemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.
3. 2-glycoprotein I-dependent anticardiolipin antibodies and risk of ischaemic stroke and myocardial infarction. The Honolulu Heart Program. Stroke 2001; 32:1701-1706.
4. Levine S, Jacobs BS. 2001: A prospective, seasonal Odyssey into antiphospholipid protein antibodies. Stroke 2001; 32:1699-1700.
5. Creagh MD, Duncan SLB, McDonell JM, Greaves M. Failure of the detection of antiphospholipid antibodies alone to predict poor pregnancy outcome. Br J Haematol. 1991; 77:4-11.
6. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H. Anti-b2-glycoprotein I and annexin-V antibodies in women with recurrent miscarriage. Br J Haematol 2001; 113:911-914.
7. Silver RM, Porter TF, Van Leeuween I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clinical consequences of "low titres". Obstet Gynecol 1996; 87:494-500.
8. Finazzi G, Brancaccio B, Moia M, Ciaverella N, Mazzucconi MG, Schinco PC, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian Registry. Am J Med 1996; 100:530-536.
9. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with different progestagen components. Lancet 1995; 46:1589-1593.
10. Lewis MA. Myocardial infarction and stroke in young women: what is the impact of oral contraceptives? Am J Obstet Gynecol 1998; 179:S68-S77.
11. Girolami A, Zanon E, Zanardi S, Saracino A, Simioni P. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies. Blood Coagul Fibrinolysis 1996; 7:497-501.
12. Bloernenkamp KW, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 2000; 160:49-52.
13. Vandenbroucke JP, van der Meet FJM, Helmerhorst FM, Rosendaal FR. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Br Med J 1996; 313:1127-1130.
14. Galli M, Ruggeri L, Barbui T. Differential effects of anti-b2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 1998; 91:1999-2004.
15. Meinardi JR, Henkens CMA, Heringa MP, van der Meer J. Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice. Blood Coagul Fibrinolysis 1997; 8:152-154.